Frank Pellegrino advises public and private companies in a broad range of transactional, corporate governance, shareholder activism and securities matters. Over the course of his career, he has completed more than $25.0 billion worth of mergers and acquisitions for public and private companies and represented issuers in public and private debt and equity offerings worth over $3.0 billion.
Frank’s practice includes the representation of both public and private clients in public and private equity and debt offerings, and acquirors and targets in mergers and acquisitions. He also counsels clients on a variety of securities law, corporate governance and public company disclosure matters.
American Bar Association — Business Law Section
American Health Lawyers Association (AHLA)
Leadership Health Care
Represented Wright Medical Group in its acquisition of Cartiva, Inc.
Represented Envision Healthcare in its definitive agreement to sell to KKR for $9.9 billion
Represented NN, Inc. (Nasdaq: NNBR) in its acquisition of Paragon Medical
Represented Smyrna Ready Mix Concrete in its acquisition of Spurlino Materials
Represented M*Modal in its acquisition of Maine-based medical transcription company
Represented Envision Healthcare in its acquisition of Meriden-Wallingford Anesthesia Group
Represented Envision Healthcare (NYSE: EVHC) in its definitive agreement to sell American Medical Response (AMR) to KKR’s portfolio company, Air Medical Group Holdings (AMGH) for $2.4 billion
Engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors of Bank of America pursuant to a settlement order entered into by Bank of America and the SEC
Represented Envision Healthcare in its acquisition of Infinity HealthCare
Represented Envision Healthcare in its acquisition of Anesthesia Associates of New London, P.C.
Mississippi Law Journal — Executive Articles Editor
University of Mississippi — Scholarship in Law